another priority area is making personalized medicine the norm by identifying substances in the blood that could be used to customize drug doses to each woman’s individual biology.
as part of its educational mission, the new fund will also support the mhi’s role as a leading center for specialists to sustain long-term impact.
“for a long time, people said pregnancy is not a disease, and being a woman is not a disease,” so research funding was rarely, if ever awarded to study sex differences, says dr. céline fiset, a pharmacist and researcher in cardiac electrophysiology at the mhi. in addition to playing a crucial role in advancing towards the goal of personalized care for women’s hearts, dr. fiset believes the new fund will help raise public awareness of early heart attack signs, which are currently missed in 78 per cent of women.
mhi scientists have long held the conviction that women’s hearts deserve dedicated attention. supplied
for many years, dr. fiset was the only woman conducting basic research at the mhi. a pioneer in her field, she has dedicated her career to studying women’s hearts and focuses on arrythmia during pregnancy, a period in which the heart works up to 50 per cent harder. “we say that pregnancy is the first stress test the heart goes through,” says dr. fiset.
during pregnancy, women run an increased risk of developing heart rhythm abnormalities. in cardiac arrhythmias, “the heart beats irregularly — or too fast, or too slow,” dr. fiset explains, due to disturbances in the heart’s electrical system. while not all arrhythmias are dangerous, they can increase risks to mother and baby.